<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38090572</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and trained immunity: the inflammatory burden of long covid.</ArticleTitle><Pagination><StartPage>1294959</StartPage><MedlinePgn>1294959</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1294959</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1294959</ELocationID><Abstract><AbstractText>Severe COVID-19 elicits excessive inflammation mediated by innate immune cells like monocytes. Recent evidence reveals extensive epigenetic changes in monocytes during recovery from severe COVID-19, including increased chromatin accessibility at genes related to cytokine production and leukocyte activation. These changes likely originate from the reprogramming of upstream hematopoietic stem and progenitor cells (HSPCs) and represent "trained immunity". HSPC-to-monocyte transmission of epigenetic memory may explain the persistence of these monocyte alterations despite their short lifespan. IL-6 appears pivotal for imprinting durable epigenetic modifications in monocytes during acute infection, with IL-1&#x3b2; potentially playing a contributory role. The poised inflammatory phenotype of monocytes post-COVID-19 may drive chronic inflammation and tissue damage, contributing to post-acute sequelae of COVID-19 symptoms. COVID-19 could also exacerbate inflammation-related diseases, such multisystem inflammatory syndromes, by altering innate immune tendencies via hematopoietic epigenetic reprogramming. Further clinical investigations quantifying inflammatory mediators and mapping epigenetic changes in HSPCs/monocytes of recovering patients are warranted. Research should also examine whether COVID-19 elicits transgenerational inheritance of epigenetic alterations. Elucidating mechanisms underlying COVID-19-induced monocyte reprogramming and developing interventions targeting key inflammatory regulators like IL-6 may mitigate the sustained inflammatory burden imposed by the aberrant trained immunity post-COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Gu, Liu, Zhang and Xu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Gu</LastName><ForeName>Jienan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Qianhui</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Jiale</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Shijie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094384" MajorTopicYN="N">Trained Immunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic inflammation</Keyword><Keyword MajorTopicYN="N">hematopoietic stem and progenitor cells</Keyword><Keyword MajorTopicYN="N">innate immune</Keyword><Keyword MajorTopicYN="N">interleukin-1&#x3b2;</Keyword><Keyword MajorTopicYN="N">interleukin-6</Keyword><Keyword MajorTopicYN="N">monocytes</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19 symptoms</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>13</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>13</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38090572</ArticleId><ArticleId IdType="pmc">PMC10713746</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1294959</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol (2020) 20:355&#x2013;62. doi:&#xa0;10.1038/s41577-020-0331-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, et al. . Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev (2020) 7:998&#x2013;1002. doi:&#xa0;10.1093/nsr/nwaa041</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa041</ArticleId><ArticleId IdType="pmc">PMC7108005</ArticleId><ArticleId IdType="pubmed">34676125</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A, Chapuis N, Dunsmore G, Goubet A-G, Dubuisson A, Derosa L, et al. . Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell (2020) 182:1401&#x2013;1418.e18. doi:&#xa0;10.1016/j.cell.2020.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefik E, Qu R, Junqueira C, Kaffe E, Mirza H, Zhao J, et al. . Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature (2022) 606:585&#x2013;93. doi:&#xa0;10.1038/s41586-022-04802-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04802-1</ArticleId><ArticleId IdType="pmc">PMC9288243</ArticleId><ArticleId IdType="pubmed">35483404</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, Asgari Mehrabadi M, Abrahim HL, Dutt N, et al. . COVID symptoms, symptom clusters, and predictors for becoming a long-hauler looking for clarity in the haze of the pandemic. Clin Nurs Res (2022) 31:1390&#x2013;8. doi:&#xa0;10.1177/10547738221125632</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10547738221125632</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med (2022) 28:1706&#x2013;14. doi:&#xa0;10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis (2022) 22:e102&#x2013;7. doi:&#xa0;10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, et al. . Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine (2021) 31:100683. doi:&#xa0;10.1016/j.eclinm.2020.100683</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekkering S, Dom&#xed;nguez-Andr&#xe9;s J, Joosten LAB, Riksen NP, Netea MG. Trained immunity: reprogramming innate immunity in health and disease. Annu Rev Immunol (2021) 39:667&#x2013;93. doi:&#xa0;10.1146/annurev-immunol-102119-073855</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-102119-073855</ArticleId><ArticleId IdType="pubmed">33637018</ArticleId></ArticleIdList></Reference><Reference><Citation>Netea MG, Dom&#xed;nguez-Andr&#xe9;s J, Barreiro LB, Chavakis T, Divangahi M, Fuchs E, et al. . Defining trained immunity and its role in health and disease. Nat Rev Immunol (2020) 20:375&#x2013;88. doi:&#xa0;10.1038/s41577-020-0285-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0285-6</ArticleId><ArticleId IdType="pmc">PMC7186935</ArticleId><ArticleId IdType="pubmed">32132681</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann E, Sanz J, Dunn JL, Khan N, Mendon&#xe7;a LE, Pacis A, et al. . BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell (2018) 172:176&#x2013;190.e19. doi:&#xa0;10.1016/j.cell.2017.12.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.031</ArticleId><ArticleId IdType="pubmed">29328912</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed S, Quintin J, Kerstens HHD, Rao NA, Aghajanirefah A, Matarese F, et al. . Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science (2014) 345:1251086. doi:&#xa0;10.1126/science.1251086</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1251086</ArticleId><ArticleId IdType="pmc">PMC4242194</ArticleId><ArticleId IdType="pubmed">25258085</ArticleId></ArticleIdList></Reference><Reference><Citation>Novakovic B, Habibi E, Wang S-Y, Arts RJW, Davar R, Megchelenbrink W, et al. . &#x3b2;-glucan reverses the epigenetic state of LPS-induced immunological tolerance. Cell (2016) 167:1354&#x2013;1368.e14. doi:&#xa0;10.1016/j.cell.2016.09.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.09.034</ArticleId><ArticleId IdType="pmc">PMC5927328</ArticleId><ArticleId IdType="pubmed">27863248</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimmers F, Donato M, Kuo A, Ashuach T, Gupta S, Li C, et al. . The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination. Cell (2021) 184:3915&#x2013;3935.e21. doi:&#xa0;10.1016/j.cell.2021.05.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.05.039</ArticleId><ArticleId IdType="pmc">PMC8316438</ArticleId><ArticleId IdType="pubmed">34174187</ArticleId></ArticleIdList></Reference><Reference><Citation>Arts RJW, Carvalho A, La Rocca C, Palma C, Rodrigues F, Silvestre R, et al. . Immunometabolic pathways in BCG-induced trained immunity. Cell Rep (2016) 17:2562&#x2013;71. doi:&#xa0;10.1016/j.celrep.2016.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.11.011</ArticleId><ArticleId IdType="pmc">PMC5177620</ArticleId><ArticleId IdType="pubmed">27926861</ArticleId></ArticleIdList></Reference><Reference><Citation>Godoy-Tena G, Barmada A, Morante-Palacios O, de la Calle-Fabregat C, Martins-Ferreira R, Ferret&#xe9;-Bonastre AG, et al. . Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines. Genome Med (2022) 14:134. doi:&#xa0;10.1186/s13073-022-01137-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-022-01137-4</ArticleId><ArticleId IdType="pmc">PMC9706884</ArticleId><ArticleId IdType="pubmed">36443794</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong J-G, Ravishankar A, Sharma S, Parkhurst CN, Grassmann SA, Wingert CK, et al. . Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell (2023) 186:3882&#x2013;902. doi:&#xa0;10.1016/j.cell.2023.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.07.019</ArticleId><ArticleId IdType="pmc">PMC10638861</ArticleId><ArticleId IdType="pubmed">37597510</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher AK, Burnham KL, Jones EM, Tan MMH, Saputil RC, Baillon L, et al. . Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19. Nat Commun (2022) 13:7947. doi:&#xa0;10.1038/s41467-022-35638-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35638-y</ArticleId><ArticleId IdType="pmc">PMC9791976</ArticleId><ArticleId IdType="pubmed">36572683</ArticleId></ArticleIdList></Reference><Reference><Citation>Peignier A, Parker D. Trained immunity and host-pathogen interactions. Cell Microbiol (2020) 22:e13261. doi:&#xa0;10.1111/cmi.13261</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.13261</ArticleId><ArticleId IdType="pmc">PMC7655595</ArticleId><ArticleId IdType="pubmed">32902895</ArticleId></ArticleIdList></Reference><Reference><Citation>Netea MG, Joosten LAB, Latz E, Mills KHG, Natoli G, Stunnenberg HG, et al. . Trained immunity: A program of innate immune memory in health and disease. Science (2016) 352:aaf1098. doi:&#xa0;10.1126/science.aaf1098</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1098</ArticleId><ArticleId IdType="pmc">PMC5087274</ArticleId><ArticleId IdType="pubmed">27102489</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabezas-Wallscheid N, Klimmeck D, Hansson J, Lipka DB, Reyes A, Wang Q, et al. . Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis. Cell Stem Cell (2014) 15:507&#x2013;22. doi:&#xa0;10.1016/j.stem.2014.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.07.005</ArticleId><ArticleId IdType="pubmed">25158935</ArticleId></ArticleIdList></Reference><Reference><Citation>You M, Chen L, Zhang D, Zhao P, Chen Z, Qin E-Q, et al. . Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19. Nat Cell Biol (2021) 23:620&#x2013;30. doi:&#xa0;10.1038/s41556-021-00690-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-021-00690-1</ArticleId><ArticleId IdType="pmc">PMC9105401</ArticleId><ArticleId IdType="pubmed">34108657</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy DM, Cox DJ, Connolly SA, Breen EP, Brugman AA, Phelan JJ, et al. . Trained immunity is induced in humans after immunization with an adenoviral vector COVID-19 vaccine. J Clin Invest (2023) 133:e162581. doi:&#xa0;10.1172/JCI162581</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI162581</ArticleId><ArticleId IdType="pmc">PMC9843058</ArticleId><ArticleId IdType="pubmed">36282571</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilliams M, Mildner A, Yona S. Developmental and functional heterogeneity of monocytes. Immunity (2018) 49:595&#x2013;613. doi:&#xa0;10.1016/j.immuni.2018.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.10.005</ArticleId><ArticleId IdType="pubmed">30332628</ArticleId></ArticleIdList></Reference><Reference><Citation>De Zuani M, Fri&#x10d; J. Train the trainer: hematopoietic stem cell control of trained immunity. Front Immunol (2022) 13:827250. doi:&#xa0;10.3389/fimmu.2022.827250</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.827250</ArticleId><ArticleId IdType="pmc">PMC8828730</ArticleId><ArticleId IdType="pubmed">35154147</ArticleId></ArticleIdList></Reference><Reference><Citation>Urb&#xe1;n P, Italiani P, Boraschi D, Gioria S. The SARS-coV-2 nucleoprotein induces innate memory in human monocytes. Front Immunol (2022) 13:963627. doi:&#xa0;10.3389/fimmu.2022.963627</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.963627</ArticleId><ArticleId IdType="pmc">PMC9343583</ArticleId><ArticleId IdType="pubmed">35928816</ArticleId></ArticleIdList></Reference><Reference><Citation>de Laval B, Maurizio J, Kandalla PK, Brisou G, Simonnet L, Huber C, et al. . C/EBP&#x3b2;-dependent epigenetic memory induces trained immunity in hematopoietic stem cells. Cell Stem Cell (2020) 26:657&#x2013;674.e8. doi:&#xa0;10.1016/j.stem.2020.01.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.01.017</ArticleId><ArticleId IdType="pubmed">32169166</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Chen X, Dan J, Hu T, Hu Y, Liu S, et al. . Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents. Signal Transduct Target Ther (2022) 7:377. doi:&#xa0;10.1038/s41392-022-01237-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01237-y</ArticleId><ArticleId IdType="pmc">PMC9666472</ArticleId><ArticleId IdType="pubmed">36379915</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle DM, Kim-Schulze S, Huang H-H, Beckmann ND, Nirenberg S, Wang B, et al. . An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med (2020) 26:1636&#x2013;43. doi:&#xa0;10.1038/s41591-020-1051-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med (2020) 46:846&#x2013;8. doi:&#xa0;10.1007/s00134-020-05991-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato G, Jones KD. Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood (1990) 75:1305&#x2013;10. doi: 10.1182/blood.V75.6.1305.1305</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V75.6.1305.1305</ArticleId><ArticleId IdType="pubmed">2310829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol (2014) 6:a016295. doi:&#xa0;10.1101/cshperspect.a016295</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a016295</ArticleId><ArticleId IdType="pmc">PMC4176007</ArticleId><ArticleId IdType="pubmed">25190079</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Driscoll DN. Emergency myelopoiesis in critical illness: lessons from the COVID-19 pandemic. Ir J Med Sci (2023) 192:831&#x2013;2. doi:&#xa0;10.1007/s11845-022-03068-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-022-03068-w</ArticleId><ArticleId IdType="pmc">PMC9203045</ArticleId><ArticleId IdType="pubmed">35711011</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze JL, Mass E, Schlitzer A. Emerging Principles in Myelopoiesis at Homeostasis and during Infection and Inflammation. Immunity (2019) 50:288&#x2013;301. doi:&#xa0;10.1016/j.immuni.2019.01.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.01.019</ArticleId><ArticleId IdType="pubmed">30784577</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao JL, Ma C, O&#x2019;Connell RM, Mehta A, DiLoreto R, Heath JR, et al. . Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis. Cell Stem Cell (2014) 14:445&#x2013;59. doi:&#xa0;10.1016/j.stem.2014.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.01.007</ArticleId><ArticleId IdType="pmc">PMC4119790</ArticleId><ArticleId IdType="pubmed">24561084</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol (2015) 16:448&#x2013;57. doi:&#xa0;10.1038/ni.3153</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3153</ArticleId><ArticleId IdType="pubmed">25898198</ArticleId></ArticleIdList></Reference><Reference><Citation>Probst AV, Dunleavy E, Almouzni G. Epigenetic inheritance during the cell cycle. Nat Rev Mol Cell Biol (2009) 10:192&#x2013;206. doi:&#xa0;10.1038/nrm2640</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2640</ArticleId><ArticleId IdType="pubmed">19234478</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitroulis I, Ruppova K, Wang B, Chen L-S, Grzybek M, Grinenko T, et al. . Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell (2018) 172:147&#x2013;161.e12. doi:&#xa0;10.1016/j.cell.2017.11.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.11.034</ArticleId><ArticleId IdType="pmc">PMC5766828</ArticleId><ArticleId IdType="pubmed">29328910</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoni A, Penco F, Mollica H, Bocca P, Prigione I, Corcione A, et al. . Spontaneous NLRP3 inflammasome-driven IL-1-&#x3b2; secretion is induced in severe COVID-19 patients and responds to anakinra treatment. J Allergy Clin Immunol (2022) 150:796&#x2013;805. doi:&#xa0;10.1016/j.jaci.2022.05.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2022.05.029</ArticleId><ArticleId IdType="pmc">PMC9272569</ArticleId><ArticleId IdType="pubmed">35835255</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriazopoulou E, Poulakou G, Milionis H, Metallidis S, Adamis G, Tsiakos K, et al. . Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med (2021) 27:1752&#x2013;60. doi:&#xa0;10.1038/s41591-021-01499-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01499-z</ArticleId><ArticleId IdType="pmc">PMC8516650</ArticleId><ArticleId IdType="pubmed">34480127</ArticleId></ArticleIdList></Reference><Reference><Citation>Potere N, Buono MGD, Caricchio R, Cremer PC, Vecchi&#xe9; A, Porreca E, et al. . Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications. eBioMedicine (2022) 85:104299. doi:&#xa0;10.1016/j.ebiom.2022.104299</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104299</ArticleId><ArticleId IdType="pmc">PMC9536001</ArticleId><ArticleId IdType="pubmed">36209522</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes S-S, et al. . The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med (2022) 3:100663. doi:&#xa0;10.1016/j.xcrm.2022.100663</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochando J, Mulder WJM, Madsen JC, Netea MG, Duivenvoorden R. Trained immunity &#x2014; basic concepts and contributions to immunopathology. Nat Rev Nephrol (2023) 19:23&#x2013;37. doi:&#xa0;10.1038/s41581-022-00633-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-022-00633-5</ArticleId><ArticleId IdType="pmc">PMC9575643</ArticleId><ArticleId IdType="pubmed">36253509</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Wang H, Yu X, Saha G, Kalafati L, Ioannidis C, et al. . Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities. Cell (2022) 185:1709&#x2013;1727.e18. doi:&#xa0;10.1016/j.cell.2022.03.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.03.043</ArticleId><ArticleId IdType="pmc">PMC9106933</ArticleId><ArticleId IdType="pubmed">35483374</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekkering S, Arts RJW, Novakovic B, Kourtzelis I, van der Heijden CDCC, Li Y, et al. . Metabolic induction of trained immunity through the mevalonate pathway. Cell (2018) 172:135&#x2013;146.e9. doi:&#xa0;10.1016/j.cell.2017.11.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.11.025</ArticleId><ArticleId IdType="pubmed">29328908</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavakis T, Mitroulis I, Hajishengallis G. Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation. Nat Immunol (2019) 20:802&#x2013;11. doi:&#xa0;10.1038/s41590-019-0402-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0402-5</ArticleId><ArticleId IdType="pmc">PMC6709414</ArticleId><ArticleId IdType="pubmed">31213716</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora VP, Loaiza RA, Soto JA, Bohmwald K, Kalergis AM. Involvement of trained immunity during autoimmune responses. J Autoimmun (2023) 137:102956. doi:&#xa0;10.1016/j.jaut.2022.102956</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102956</ArticleId><ArticleId IdType="pubmed">36526524</ArticleId></ArticleIdList></Reference><Reference><Citation>Theobald SJ, Simonis A, Georgomanolis T, Kreer C, Zehner M, Eisfeld HS, et al. . Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19. EMBO Mol Med (2021) 13:e14150. doi:&#xa0;10.15252/emmm.202114150</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114150</ArticleId><ArticleId IdType="pmc">PMC8350892</ArticleId><ArticleId IdType="pubmed">34133077</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Bosurgi L, et al. . Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. J Med Virol (2023) 95:e28364. doi:&#xa0;10.1002/jmv.28364</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28364</ArticleId><ArticleId IdType="pmc">PMC9878213</ArticleId><ArticleId IdType="pubmed">36458566</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, Boustani K, Ogger PP, Papadaki A, Tonkin J, Orton CM, et al. . Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity (2022) 55:542&#x2013;556.e5. doi:&#xa0;10.1016/j.immuni.2022.01.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.017</ArticleId><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnacker S, Hartung F, Henkel F, Quaranta A, Kolmert J, Priller A, et al. . Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages. Mucosal Immunol (2022) 15:515&#x2013;24. doi:&#xa0;10.1038/s41385-021-00482-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00482-8</ArticleId><ArticleId IdType="pmc">PMC9038526</ArticleId><ArticleId IdType="pubmed">35288643</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol (2023) 21:133&#x2013;46. doi:&#xa0;10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, Celi A, et al. . Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med (2003) 197:1585&#x2013;98. doi:&#xa0;10.1084/jem.20021868</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20021868</ArticleId><ArticleId IdType="pmc">PMC2193915</ArticleId><ArticleId IdType="pubmed">12782720</ArticleId></ArticleIdList></Reference><Reference><Citation>Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, et al. . Platelet gene expression and function in patients with COVID-19. Blood (2020) 136:1317&#x2013;29. doi:&#xa0;10.1182/blood.2020007214</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007214</ArticleId><ArticleId IdType="pmc">PMC7483430</ArticleId><ArticleId IdType="pubmed">32573711</ArticleId></ArticleIdList></Reference><Reference><Citation>Spahn JH, Kreisel D. Monocytes in sterile inflammation: recruitment and functional consequences. Arch Immunol Ther Exp (Warsz) (2014) 62:187&#x2013;94. doi:&#xa0;10.1007/s00005-013-0267-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00005-013-0267-5</ArticleId><ArticleId IdType="pmc">PMC4294530</ArticleId><ArticleId IdType="pubmed">24310705</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Dean LS, Jiyarom B, Gangcuangco LM, Shah P, Awamura T, et al. . Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals. Front Immunol (2023) 14:1151780. doi:&#xa0;10.3389/fimmu.2023.1151780</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1151780</ArticleId><ArticleId IdType="pmc">PMC10106598</ArticleId><ArticleId IdType="pubmed">37077911</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Laurent S, Onur OA, Kleineberg NN, Fink GR, Schweitzer F, et al. . A systematic review of neurological symptoms and complications of COVID-19. J Neurol (2021) 268:392&#x2013;402. doi:&#xa0;10.1007/s00415-020-10067-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10067-3</ArticleId><ArticleId IdType="pmc">PMC7370630</ArticleId><ArticleId IdType="pubmed">32691236</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajishengallis G, Li X, Divaris K, Chavakis T. Maladaptive trained immunity and clonal hematopoiesis as potential mechanistic links between periodontitis and inflammatory comorbidities. Periodontol 2000 (2022) 89:215&#x2013;30. doi:&#xa0;10.1111/prd.12421</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/prd.12421</ArticleId><ArticleId IdType="pmc">PMC9018499</ArticleId><ArticleId IdType="pubmed">35244943</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Iorio M, Cook CE, Vanni KMM, Patel NJ, D&#x2019;Silva KM, Fu X, et al. . DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study. Semin Arthritis Rheum (2022) 55:152025. doi:&#xa0;10.1016/j.semarthrit.2022.152025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2022.152025</ArticleId><ArticleId IdType="pmc">PMC9116968</ArticleId><ArticleId IdType="pubmed">35617780</ArticleId></ArticleIdList></Reference><Reference><Citation>Das A, Sinha M, Datta S, Abas M, Chaffee S, Sen CK, et al. . Monocyte and macrophage plasticity in tissue repair and regeneration. Am J Pathol (2015) 185:2596&#x2013;606. doi:&#xa0;10.1016/j.ajpath.2015.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2015.06.001</ArticleId><ArticleId IdType="pmc">PMC4607753</ArticleId><ArticleId IdType="pubmed">26118749</ArticleId></ArticleIdList></Reference><Reference><Citation>Netea MG, Ziogas A, Benn CS, Giamarellos-Bourboulis EJ, Joosten LAB, Arditi M, et al. . The role of trained immunity in COVID-19: Lessons for the next pandemic. Cell Host Microbe (2023) 31:890&#x2013;901. doi:&#xa0;10.1016/j.chom.2023.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2023.05.004</ArticleId><ArticleId IdType="pmc">PMC10265767</ArticleId><ArticleId IdType="pubmed">37321172</ArticleId></ArticleIdList></Reference><Reference><Citation>Riksen NP, Bekkering S, Mulder WJM, Netea MG. Trained immunity in atherosclerotic cardiovascular disease. Nat Rev Cardiol (2023) 20:799&#x2013;811. doi:&#xa0;10.1038/s41569-023-00894-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-023-00894-y</ArticleId><ArticleId IdType="pubmed">37322182</ArticleId></ArticleIdList></Reference><Reference><Citation>Leentjens J, Bekkering S, Joosten LAB, Netea MG, Burgner DP, Riksen NP. Trained innate immunity as a novel mechanism linking infection and the development of atherosclerosis. Circ Res (2018) 122:664&#x2013;9. doi:&#xa0;10.1161/CIRCRESAHA.117.312465</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.312465</ArticleId><ArticleId IdType="pubmed">29367213</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeljeli MM, Adamopoulos IE. Innate immune memory in inflammatory arthritis. Nat Rev Rheumatol (2023) 19:627&#x2013;39. doi:&#xa0;10.1038/s41584-023-01009-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-023-01009-0</ArticleId><ArticleId IdType="pmc">PMC10721491</ArticleId><ArticleId IdType="pubmed">37674048</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A, Gonz&#xe1;lez-Cuadrado C, Chivite-Lacaba M, Cabrera-Marante O, Laguna-Goya R, Almendro-Vazquez P, et al. . Alterations in circulating monocytes predict COVID-19 severity and include chromatin modifications still detectable six months after recovery. Biomedicines (2021) 9:1253. doi:&#xa0;10.3390/biomedicines9091253</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9091253</ArticleId><ArticleId IdType="pmc">PMC8471575</ArticleId><ArticleId IdType="pubmed">34572439</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J-X, Agbana YL, Sun Z-S, Fei S-W, Zhao H-Q, Zhou X-N, et al. . Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis. Infect Dis Poverty (2023) 12:43. doi:&#xa0;10.1186/s40249-023-01086-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-023-01086-z</ArticleId><ArticleId IdType="pmc">PMC10123579</ArticleId><ArticleId IdType="pubmed">37095536</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L, Orban ZS, Koralnik IJ. Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence. Front Med (2022) 9:1003103. doi:&#xa0;10.3389/fmed.2022.1003103</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1003103</ArticleId><ArticleId IdType="pmc">PMC9537824</ArticleId><ArticleId IdType="pubmed">36213654</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat Med (2023) 29:1&#x2013;11. doi:&#xa0;10.1038/s41591-023-02521-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A, Vasaikar SV, Szeto GL, Lemos MP, Czartoski JL, MacMillan H, et al. . Persistent serum protein signatures define an inflammatory subcategory of long COVID. Nat Commun (2023) 14:3417. doi:&#xa0;10.1038/s41467-023-38682-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38682-4</ArticleId><ArticleId IdType="pmc">PMC10252177</ArticleId><ArticleId IdType="pubmed">37296110</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A, Vasaikar SV, Lemos MP, Moodie Z, Pebworth M-PL, Henderson KE, et al. . Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. bioRxiv (2021) 19:2021.05.26.442666 doi:&#xa0;10.1101/2021.05.26.442666</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.26.442666</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzmarski N, Dom&#xed;nguez-Andr&#xe9;s J, Cirovic B, Renieris G, Ciarlo E, Le Roy D, et al. . Transmission of trained immunity and heterologous resistance to infections across generations. Nat Immunol (2021) 22:1382&#x2013;90. doi:&#xa0;10.1038/s41590-021-01052-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01052-7</ArticleId><ArticleId IdType="pubmed">34663978</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>